Is Factor XII Deficiency Related to Recurrent Miscarriage?

ABSTRACT

Factor XII (FXII) is an important protease that plays a major role in the initiation of the intrinsic pathway of blood coagulation. Although congenital FXII deficiency is not associated with a clinical bleeding tendency, it can be identified on a routine coagulation test, such as a prolonged activated partial thromboplastin time. This deficiency is a rare autosomal recessive disorder. It is still unclear whether FXII deficiency causes any disorders during pregnancy. Recurrent miscarriages and placental abruption were reported in cases with FXII deficiency. We successfully treated a woman whose pregnancy was complicated by congenital FXII deficiency. We report her clinical courses of gestation, delivery, and puerperium and discuss the role of maternal FXII associated with pregnancy. In our case, courses of gestation and delivery were normal. Postpartum uterine bleeding was, however, prolonged due to a subinvolution of the puerperal uterus. Our results indicate that, except for postpartum uterine contraction, FXII does not play a major role in gestation and delivery. We suggest that FXII deficiency is not associated with recurrent miscarriage and that normal gestation and vaginal delivery are possible even in cases with congenital FXII deficiency. We assert that the possible correlation of FXII deficiency with recurrent miscarriage merits reevaluation.

KEYWORD

Factor XII deficiency - miscarriage - kinin formation - postpartum bleeding - uterine contraction

REFERENCES

• 1 Halbmayer W M, Haushofer A, Schon R. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.  Thromb Haemost . 1994;  71 68-72
• 2 Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia.  Br J Haematol . 2000;  109 364-366
• 3 Asahina T, Kobayashi T, Okada Y. Studies on the role of adhesive proteins in maintaining pregnancy.  Horm Res . 1998;  37-45 (37-45)
• 4 Saidi P, Siegelman M, Mitchel V B. Effect of factor XII deficiency on pregnancy and parturition.  Thromb Haemost . 1979;  41 523-528
• 5 Lao T T, Lewinsky R M, Ohlsson A, Cohen H. Factor XII deficiency and pregnancy.  Obstet Gynecol . 1991;  78 491-493
• 6 Braulke I, Pruggmayer M, Melloh P, Hinney B, Köstering H, Günther E. Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters?.  Fertil Steril . 1993;  59 98-101
• 7 Schved J F, Gris J C, Neveu S, Dupaigne D, Mares P. Factor XII congenital deficiency and early spontaneous abortion.  Fertil Steril . 1989;  52 335-336
• 8 Gris J C, Ripart-Neveu S, Maugard C. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study.  Thromb Haemost . 1997;  77 1096-1103
• 9 Proctor R R, Rapaport S I. The partial thromboplastin time with kaolin.  Am J Clin Pathol . 1961;  36 212-219
• 10 Amundsen E, Gallimore M J, Aasen A O, Larsbraaten M, Lyngaas K. Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors.  Thromb Res . 1978;  13 625-636
• 11 Maki M, Soga K, Gotoh K. The kinin-forming enzyme system in pregnancy and obstetrical DIC.  Bibl Haematol . 1983;  49 625-636
• 12 Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage.  Fertil Steril . 1999;  72 765-774
• 13 Yamada H, Kato E H, Ebina Y. Factor XII deficiency in women with recurrent miscarriage.  Gynecol Obstet Invest . 2000;  49 80-83
• 14 Miyazawa K, Wang Y, Minoshima S. Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene.  Eur J Biochem . 1998;  258 355-361
• 15 Uehara Y, Minowa O, Mori C. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/ scatter factor.  Nature . 1995;  373 702-705
• 16 Jones D W, Gallimore M J, Harris S L, Winter M. Antibodies to factor XII associated with lupus anticoagulant.  Thromb Haemost . 1999;  81 387-390
• 17 Gallimore M J, Jones D W, Winter M. Factor XII determinations in the presence and absence of phospholipid antibodies.  Thromb Haemost . 1998;  79 87-90
• 18 Branch D W. Antiphospholipid antibodies and reproductive outcome: the current state of affairs.  J Reprod Immunol . 1998;  38 75-87
• 19 Franklin R D, Hollier N, Kutteh W H. β2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss.  Fertil Steril . 2000;  73 531-535
• 20 Tans G, Rosing J. Structural and function characterization of factor XII.  Semin Thromb Hemost . 1987;  13 1-14
• 21 Suzuki S, Morishita S. The relationship between the onset of labor mechanisms and the hemostatic system.  Immunopharmacology . 1999;  43 133-140
• 22 Suzuki S, Murakoshi T, Sakamoto W. Studies on the various causal factors related to hypercoagulability in the field of obstetrics-with special reference to the onset of DIC as viewed from the changing of kinin-kallikrein system and fibrinopeptide A.  Adv Exp Med Biol . 1983;  156 1055-1065
• 23 Chao J, Buse J, Shimamoto K, Margolius H S. Kallikrein-induced uterine contraction independent of kinin formation.  Proc Natl Acad Sci USA . 1981;  78 6154-6157